Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00240097
Status:
COMPLETED
Last Update Posted:
2014-11-27
First Post:
2005-10-13
Brief Title:
Study of Sequential Topoisomerase IrinotecanOxaliplatin - Etoposide Carboplatin in Extensive Small Cell Lung Cancer SCLC
Sponsor:
University of Alabama at Birmingham
Organization:
University of Alabama at Birmingham
Organization Data
Organization:
University of Alabama at Birmingham
Class:
OTHER
Study ID:
F041222002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Alabama at Birmingham
Lead Sponsor Class:
OTHER
Responsible Party:
Francisco RobertMD
Responsible Party Title:
Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Alabama at Birmingham
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi-Synthelabo | INDUSTRY |
| Amgen | INDUSTRY |